This is in agreement with the above reported studies showing that wtp53 inhibited EZH2 [13] and that EZH2 inhibition was able to induce a cytotoxic effect against pancreatic cancer cells only if they carried wtp53, by inducing its activation [12]. Here, EZH2 is linked to pancreatic neoplasm.